Mr Jean-Marc Grosperrin > Dentons > Paris, France > Lawyer Profile

Dentons
5 BOULEVARD MALESHERBES
75008 PARIS
France

Work Department

Corporate and Healthcare, Life Sciences

Position

Jean-Marc Grosperrin, a Partner in Dentons’ Paris office, is primarily involved in French and cross-border acquisitions, private equity transactions and industrial M&A transactions. Jean-Marc regularly advises major international groups as well as mid-sized companies in a variety of sectors.

Besides advising French and foreign companies on their acquisitions or divestitures in France and abroad, he also represents investment funds and managers in leveraged transactions.

Jean-Marc is Global Chair of Dentons’ Life Science & Healthcare group and Co-head of the Europe and Paris Life Sciences groups. He also serves as a member of Dentons Europe Board.

Career

Joined Dentons (formerly Salans) in 2004
Started his career in 1998 at Willkie Farr & Gallagher, first in Paris and then in New-York, where he concentrated on private equity acquisitions, mergers and restructuring issues

Languages

English, French

Memberships

Admitted to the Paris Bar in 1998

Education

University of Notre Dame, Indiana, LL.M., Magna Cum Laude (1996)
University of Clermont-Ferrand, DEA in Business Law (1994)
University of Clermont-Ferrand, Maîtrise in Business Law (1993)

Lawyer Rankings

France > Industry focus: Healthcare and life sciences

(Leading individuals)

Jean-Marc GrosperrinDentons

Jointly led by the ‘attentive, extremely professional’ Jean-Marc Grosperrin, Julien Le Guyader, and Anne-Laure Marcerou, the team at Dentons handles the full gamut of issues in life sciences for its diverse client list, including Panasonic, Pfizer, and Laboratoires Servier. Grosperrin is particularly adept at advising global pharma corporations on domestic and cross-border M&A and private equity transactions, while Marcerou is noted for her deep knowledge of the structuring and negotiation of transactions involving biotech and medtech companies. Le Guyader regularly handles market access mandates and issues concerning international tax law. Having joined the team in February 2023 from Dechert LLP, Jessica Garestier exhibits vast regulatory expertise, particularly in relation to market access, promotion, and health product compliance. Pascale Poupelin is a key name of note within the practice, particularly for market access matters.